Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

MEDOCOBAL CD3

Class 5Status: Objected
Application Number5797057
Trademark Status
Objected
Trademark Class5
Application Date2023-02-06
Proprietor NameMEDOGENA PHARMACEUTICAL PRIVATE LIMITED
Appropriate OfficeDELHI
StateUTTAR PRADESH
Trademark TypeWORD
User DetailsProposed to be used
Agent NameANUPAM TRIPATHI[33300]
Agent AddressRZD-3/68, STREET NUMBER 7, MAHAVIR ENCLAVE, NEW DELHI-110058.
Goods And Services Details[CLASS : 5] MEDICINAL AND PHARMACEUTICAL PREPARATIONS.

Identical Trademarks

Similar trademarks found for this brand

1 found
BrandClassStatus
MEDOCOBAL CD35Objected
Showing up to 6 identical trademarksView more on LEDGERS→

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about MEDOCOBAL CD3.

What is the status of trademark application 5797057?
The current status of trademark application 5797057 for MEDOCOBAL CD3 is Objected.
What is the trademark class of MEDOCOBAL CD3?
MEDOCOBAL CD3 is registered under trademark class 5.
Who is the proprietor of MEDOCOBAL CD3?
The proprietor of MEDOCOBAL CD3 is MEDOGENA PHARMACEUTICAL PRIVATE LIMITED.
When was trademark application 5797057 filed?
Trademark application 5797057 for MEDOCOBAL CD3 was filed on 2023-02-06.